retatrutide type 2 diabetes trial results Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA Retatrutide Phase 2: Type 2

Why Does Hypoglycaemia Happen on GLP-1s

This triple-pathway activation addresses blood glucose regulation, appetite suppression, AND increased energy expenditure at the same time

Employers need to think about GLP-1s as one tool in a broader care strategy safe, evidence-based, and integrated with the rest of an employees health journey. The takeaway: this isnt a benefits decision

Another study found that psychiatric AEs only accounted for 1.2 % of total reports for semaglutide, liraglutide, and tirzepatide [47,48], although rare case reports have suggested suicide as a serious psychiatric AE of semaglutide 2.4 mg [[49], [50], [51], [52]]

A 3ml luer-lock syringe is ideal for measuring 1-2ml of water precisely

Some risk factors to be aware of include demographic factors, such as being female (women are more prone to gallstones generally) and being over the age of 40